Impax Laboratories Inc (NASDAQ:IPXL)
| 18.61 Data as of May 22 |  +0.10 / +0.54%Today’s Change | 14.41 Today|||52-Week Range 27.25 | -9.18% Year-to-Date |
Latest IPXL News | Press Releases
No recent news for Impax Laboratories Inc.
Today’s Trading
| Previous close | 18.51 |
| Today’s open | 18.46 |
| Day’s range | 18.46 - 18.87 |
| Volume | 564,414 |
| Average volume (3 months) | 1,211,777 |
| Market cap | $1.3B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -15.46% |
| Earnings growth (this year) | -88.96% |
| Earnings growth (next 5 years) | +15.13% |
| Revenue growth (last year) | +13.41% |
| P/E ratio | 8.5 |
| Price/Sales | 2.31 |
| Price/Book | 1.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INFIInfinity Pharmaceuti... | -2.01 | -8.00% |
| ACORAcorda Therapeutics ... | -0.32 | -0.99% |
| VVUSVIVUS Inc | +0.36 | +2.74% |
| ACADACADIA Pharmaceutica... | -0.37 | -2.68% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $581.7M |
| Annual profit (last year) | $55.9M |
| Net profit margin | 9.61% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Chung-Chiang Hsu, PhD |
Chief Financial Officer & Senior Vice President Bryan M. Reasons, MBA, CPA |
Corporate headquarters Hayward, California |
Forecasts
